Molecular building blocks and nutrients as a novel cancer treatment
In this invention, a novel cancer drug is formed by Cu(II) and Fe(III) binding the medicinal molecule Paclitaxel (PAC). This complexation increases the water solubility of the taxane, alters the structure so resistance mechanisms do not recognize it, and adds additional toxicity. The copper (II) spe...
Saved in:
| Main Authors: | Thomas Manning, Teighlor Livingston, Capri Persaud, Akshil Patel, James Nienow |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Elsevier
2024-01-01
|
| Series: | Invention Disclosure |
| Subjects: | |
| Online Access: | http://www.sciencedirect.com/science/article/pii/S2772444124000028 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Targeting metabolic reprogramming in glioblastoma as a new strategy to overcome therapy resistance
by: Simona D’Aprile, et al.
Published: (2025-02-01) -
Un autore “celato”: Paolo Mantegazza e l’incontro intellettuale con Aby Warburg
by: Giuliana Di Martino
Published: (2023-12-01) -
Investigation of the synergistic effect of metformin and FX11 on PANC-1 cell lines
by: Melike Bayindir-Bilgic, et al.
Published: (2025-03-01) -
Tumor‐Associated Lactic Acidosis and Early Death in Patients With Lymphoma
by: Bahaa Atamna, et al.
Published: (2025-04-01) -
GLUT1 as a Potential Therapeutic Target in Glioblastoma
by: FNU Ruchika, et al.
Published: (2025-05-01)